[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Ip Group Plc LSE:IPO London Ordinary Share GB00B128J450 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -8.00 -6.67% 112.00 112.00 112.40 118.00 112.00 116.80 4,280,586 16:35:12
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 0.0 186.1 17.5 6.4 1,190

Ip Share Discussion Threads

Showing 2176 to 2200 of 3200 messages
Chat Pages: Latest  92  91  90  89  88  87  86  85  84  83  82  81  Older
DateSubjectAuthorDiscuss
24/2/2021
22:50
Expecting some useful new investments to start to allocate that cash.
p1nkfish
24/2/2021
22:38
For better or worse I'm really looking forward to them - no more chat just numbers. (Should be good, however, IMO)
podgyted
24/2/2021
13:08
Results for 2020 on Wednesday 10 March 2021 This is the same Wednesday as last year. There is normally an update on post year end news. If you have previously registered for IPGroup events there is just a box to tick. It's worth logging on early in case zoom has an update waiting for you!
bamboo2
24/2/2021
13:02
FOR RELEASE ON 24 February 2021 IP Group - Notice of results IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property-based businesses, announces that it intends to publish its annual financial results for the year ended 31 December 2020 on Wednesday 10 March 2021. The results will be available via the London Stock Exchange's Regulatory News Service (RNS) and on the Investor Relations section of the company's website at www.ipgroupplc.com . Key members of IP Group plc's leadership team will host a webinar to discuss the results and address questions from qualified analysts and investors at 10:00 am London time on March 10th. For more details or to register as a participant please visit Https://www.ipgroupplc.com/events
bamboo2
22/2/2021
13:25
Sunday times business article on Woodford
robertspc1
22/2/2021
07:44
rob, do you have a link? I read somewhere last week ONT listing plans were London based.
bamboo2
21/2/2021
20:39
More press speculation that ONT poised to IPO ... SPAC would be even better
robertspc1
19/2/2021
08:54
19 February 2021 COVID-19 mobile testing labs management contract SourceBio to support roll-out of mobile units containing Oxford Nanopore's LamPORE test Mobile labs to meet demand for decentralised community testing as part of the pandemic response SourceBio International plc (AIM: SBI), the international provider of integrated state-of-the-art laboratory services and products , announces that it has entered into an agreement with Mitie Security Limited ("Mitie") to manage the delivery of community based COVID-19 testing services through mobile testing units. SourceBio will manage the delivery of the mobile COVID-19 testing laboratory service currently being deployed in a Department of Health and Social Care ("DHSC") pilot scheme . SourceBio will oversee all laboratory operations and processes and will have responsibility for all clinical governance, quality assurance, staff training, sample processing and information management. Currently four mobile testing laboratories using Oxford Nanopore's LamPORE tests for COVID-19 have been deployed in the pilot which has been launched to support the Governments community-based testing efforts and ensure that COVID-19 testing is available for surge or increased infectious status within a specified region. SourceBio will manage the mobile testing service on behalf of Mitie for the remainder of the pilot and is working towards continued involvement in a potential UK-wide programme. Larger mobile testing units can process in excess of 1,500 samples a day, with 1,000 tests a day targeted for smaller vehicles. Patient swab samples are processed onboard with results provided within 24 hours. Oxford Nanopore's LamPORE test has been shown to be highly accurate for the detection of SARS-CoV-2. A study carried out by teams across the UK on over 23,000 samples have demonstrated gold-standard accuracy of the LamPORE test, showing >99.5% sensitivity and specificity, making LamPORE highly effect for testing symptomatic and asymptomatic individuals. SourceBio has worked closely with the DHSC providing COVID-19 antigen RT-PCR testing services using the Company's laboratory facility. SourceBio has processed approaching 1,000,000 COVID-19 antigen RT-PCR tests for the DHSC and the NHS, Private Hospital Groups and Commercial customers since first offering its service in May 2020. Jay LeCoque, Executive Chairman, commented: "We are very proud to support the UK's national testing effort to bring gold standard testing to the local communities as part of the effort to get the nation back to work. The need for localised testing and monitoring of infections is critical as the vaccine program accelerates. This project also highlights our continued work with the DHSC on multiple fronts as they work to manage the pandemic as it evolves."
bamboo2
18/2/2021
05:13
From Jan fact sheet of Amati UK Smaller Cos fund: "A new position was taken in IP Group, the early stage investor in healthcare, cleantech and technology companies, where enhanced future investment prospects contrast with a longer term underperformance of the shares and a decent discount to Net Asset Value." Will only be a small position, but is a quality fund so worth noting.
rambutan2
17/2/2021
12:22
rambutan2 & bamboo2 missed post 2 thanks looking forward then to AR2020 ...
leoboy
17/2/2021
07:53
IP Group plc - Portfolio company ApcinteX acquired by Centessa Pharmaceuticals IP Group plc notes the announcement from Centessa Pharmaceuticals that it has launched with a $250m financing round after having acquired a number of assets including IP Group portfolio company ApcinteX Ltd' Following these transactions, IP Group's resulting minority stake in Centessa is valued at £19.0m, representing a fair value gain of £11.0m from the holding value of ApcinteX at 30 June 2020. ApcinteX is developing SerpinPC, a specific inhibitor of the anticoagulant protease activated protein C (APC), for the treatment for hemophilia A and hemophilia B, with or without inhibitors..
masurenguy
16/2/2021
22:55
See link in header of this thread!! courtesy of bamboo2.
rambutan2
16/2/2021
20:56
if the AR was 18-04-19 where is 2020 ? please // am trying to establish also who are the shareholders - cannot see on IP Group website // is it me , or is it me ? anyone please point me in the right direction ?
leoboy
16/2/2021
18:45
eeza, In trading this uptrend I have been very lucky and only been badly caught out once in early January 2021 when my assumptions about Invesco were proven incorrect. Not sure if I would have just been better off with a buy and hold over the last year or so, but in the main, trading IPO has been great fun and a very rewarding experience. Very much hoping I can do something similar with GROW, but still getting my head around the situation.
bamboo2
16/2/2021
17:48
That's the good (if things go well) & the bad (if they don't) of overweight holdings.
eeza
16/2/2021
17:33
eeza, I do sometimes wonder how much of the churn is people like me! Because I average in and out it's difficult to work out precisely the total volume involved.
bamboo2
16/2/2021
16:36
That's probably your trades, bamboo !!
eeza
16/2/2021
16:26
Wetpantz, Quick check of decimal points! Visible volume so far is approx 5.3m. This is more like 0.5% of the co., rather than 5% edit, still good volume though!
bamboo2
16/2/2021
15:59
Agree with p1nk, strong move up today on big volume c. 5% of market cap traded. maybe announcement on ONT ipo imminent? Has been a few speculative mentions in press over past 2 wks. Barrons, FT, Telegraph.
wetpantz
16/2/2021
12:18
More going on to cause this than just ONT. This is not all because of nanopore imho. Something else is going on.
p1nkfish
16/2/2021
12:17
So far, every time I come across a chart looking like this, even though can be turbulent, it just marches higher over time. Close yesterday was a very good sign.
p1nkfish
16/2/2021
12:04
rob, thinking big sellers were gone, I mistimed a large buy in January. I eventually doubled up on the way down to 90, but ended up with a very large position, so have been rebalancing over the past few days. Still have basic holding.
bamboo2
16/2/2021
11:33
Genomics coverage is everywhere as a result of Covid. Investors flush with cash, IPO and SPAC deals daily, Illumina at 5 year high, may never be a better time for an ONT deal. I wouldn't be a seller
robertspc1
16/2/2021
11:09
Hi p1nkfish, I have been letting go of the trading shares today as I have a possible turn noted on the chart 15-16/2/2021. p/f was nearly 80% ipo, so feeling quite relieved! :-)
bamboo2
16/2/2021
10:57
Heading higher still imho. Something changing or news of some sort leaking. Trend is friendly overall.
p1nkfish
Chat Pages: Latest  92  91  90  89  88  87  86  85  84  83  82  81  Older
ADVFN Advertorial
Your Recent History
LSE
IPO
Ip
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211127 15:58:00